6.98
-0.11 (-1.55%)
| Previous Close | 7.09 |
| Volume | 96,924 |
| Price / Sales | 2.12 |
| Price / Book | 5.84 |
| 52 Weeks Range |
| Profit Margin | -99.17% |
| Operating Margin (TTM) | -11.05% |
| Diluted EPS (TTM) | -4.86 |
| Quarterly Revenue Growth (YOY) | 33.70% |
| Total Debt/Equity (MRQ) | 14.02% |
| Current Ratio (MRQ) | 1.81 |
| Operating Cash Flow (TTM) | -3.91 M |
| Levered Free Cash Flow (TTM) | 19.59 M |
| Return on Assets (TTM) | -6.31% |
| Return on Equity (TTM) | -304.05% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | LENSAR, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.79 |
|
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 19.64% |
| % Held by Institutions | 44.03% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |